Hims & Hers Health Net Income 2020-2024 | HIMS

Hims & Hers Health annual/quarterly net income history and growth rate from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Hims & Hers Health net income for the quarter ending September 30, 2024 was $0.076B, a 1098.92% decline year-over-year.
  • Hims & Hers Health net income for the twelve months ending September 30, 2024 was $0.101B, a 383.65% decline year-over-year.
  • Hims & Hers Health annual net income for 2023 was $-0.024B, a 64.15% decline from 2022.
  • Hims & Hers Health annual net income for 2022 was $-0.066B, a 38.99% decline from 2021.
  • Hims & Hers Health annual net income for 2021 was $-0.108B, a 494.34% increase from 2020.
Hims & Hers Health Annual Net Income
(Millions of US $)
2023 $-24
2022 $-66
2021 $-108
2020 $-18
2019 $-72
2018 $
Hims & Hers Health Quarterly Net Income
(Millions of US $)
2024-09-30 $76
2024-06-30 $13
2024-03-31 $11
2023-12-31 $1
2023-09-30 $-8
2023-06-30 $-7
2023-03-31 $-10
2022-12-31 $-11
2022-09-30 $-19
2022-06-30 $-20
2022-03-31 $-16
2021-12-31 $-31
2021-09-30 $-16
2021-06-30 $-9
2021-03-31 $-51
2020-12-31 $-5
2020-09-30 $-6
2020-06-30 $-1
2020-03-31 $-6
2019-12-31
2019-09-30 $0
2019-06-30 $-0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.506B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00